Journal Mobile Options
Table of Contents
Vol. 12, No. 6, 2001
Issue release date: November–December 2001
Dement Geriatr Cogn Disord 2001;12:400–407

Repeated Pain Assessment in Alzheimer’s Disease

Scherder E. · Bouma A. · Slaets J. · Ooms M. · Ribbe M. · Blok A. · Sergeant J.
Department of Clinical Neuropsychology, Vrije Universiteit, Amsterdam, The Netherlands

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


In previous studies, patients with probable Alzheimer’s disease (AD) have indicated that they experienced less pain intensity and affect from their painful conditions than nondemented elderly persons. However, in those studies, pain assessment occurred only once. Therefore, it may be possible that pain which had occurred, for example, a day earlier, could have been forgotten. Therefore, in the present study, AD patients’ pain was assessed daily, i.e. once a day and even three times a day, during a longer period. The results parallel those of earlier studies, i.e. compared to elderly persons without dementia, AD patients appear to perceive less pain intensity and pain affect. These findings support the hypothesis that AD is characterized by an alteration in pain experience.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Ferrell BA, Ferrell BR, Osterweil D: Pain in the nursing home. J Am Geriatr Soc 1990;38:409–414.
  2. Marzinski LR: The tragedy of dementia: Clinically assessing pain in the confused, nonverbal elderly. J Gerontol Nurs 1991;17:25–28.
  3. Ferrell BA: Pain evaluation and management in the nursing home. Ann Intern Med 1995;123:681–687.
  4. Ferrell BA, Ferrell BR, Rivera L: Pain in cognitively impaired nursing home patients. J Pain Symptom Manage 1995;10:591–598.
  5. Parmelee PA, Smith B, Katz IR: Pain complaints and cognitive status among elderly institution residents. J Am Geriatr Soc 1993;41:517–522.
  6. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239–259.
  7. Swaab DF: Neurobiology and neuropathology of the human hypothalamus; in Bloom FE, Björklund A, Hökfelt T (eds): Handbook of Chemical Neuroanatomy. I. The Primate Nervous System. Amsterdam, Elsevier Science, 1997, vol 13, pp 39–136.
  8. Mense S: Basic neurobiologic mechanisms of pain and analgesia. Am J Med 1983;14:4–14.
  9. Giesler GJ, Katter JT, Dado RJ: Direct spinal pathways to the limbic system for nociceptive information. Trends Neurosci 1994;17:244–250.
  10. Farrell MJ, Katz B, Helme RD: The impact of dementia on the pain experience. Pain 1996;67:7–15.
  11. Scherder EJA, Bouma A: Is decreased use of analgesics in Alzheimer disease due to a change in the affective component of pain? Alzheimer Dis Assoc Disord 1997;11:171–174.
  12. Scherder E, Bouma A, Borkent M, Rahman O: Alzheimer patients report less pain intensity and pain affect than non-demented elderly. Psychiatry 1999;62:265–272.
  13. Scherder EJA, Bouma A: Visual analogue scales for pain assessment in Alzheimer’s disease. Gerontology 2000;46:47–53.
  14. Salzmann E: Importance of the hippocampus and parahippocampus with reference to normal and disordered memory function. Fortschr Neurol Psychiatr 1992;60:163–176.
  15. Soininen HS, Partanen K, Pitkänen A, Vainio P, Hänninen T, Hallikainen M, Koivisto K, Riekkinen PJ: Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment. Neurology 1994;44:1660–1668.
  16. Carpenter GA, Grossberg S: Normal and amnesic learning, recognition and memory by a neural model of cortico-hippocampal interactions. Trends Neurosci 1993;16:131–137.
  17. Reisberg B, Ferris SH, De Leon MJ, Crook T: The Global Deterioration Scale for assessment of primary dementia. Am J Psychiatry 1982;139:1136–1139.
  18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: Reports of the NINCDS-ADRDA workgroup under the auspices of the Department of Health and Human Services task force on Alzheimer’s disease. Neurology 1984;34:939–944.
  19. Breakhus A, Laake K, Engedal K: The Mini-Mental State Examination: Identifying the most efficient variables for detecting cognitive impairment in the elderly. J Am Geriatr Soc 1992;40:1139–1145.
  20. Folstein MF, Folstein SE, McHugh PR: Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  21. McGrath PA, Seifert CE, Speechley KN, Booth JC, Stitt L, Gibson MC: A new analogue scale for assessing children’s pain: An initial validation study. Pain 1996;64:435–443.
  22. Bieri D, Reeve RA, Champion GD, Addicoat L, Ziegler JB: The Face Pain Scale for the self-assessment of the severity of pain experienced by children: Development, initial validation, and preliminary investigation for ratio scale properties. Pain 1990;41:139–150.
  23. Melzack R: The short-form McGill pain questionnaire. Pain 1987;30:191–197.
  24. Verkes R, Vanderiet K, Vertommen H, van der Kloot WA, Van der Meij J: De MPQ-DLV: een standaard Nederlandse versie van de McGill Pain Questionnaire voor België en Nederland. Lisse, Swets & Zeitlinger, 1989.
  25. Feldt K: Checklist of non-verbal pain indicators (CNPI). Pain Management Nursing, in press.
  26. Richards JS, Nepomuceno C, Riles M, Suer Z: Assessing pain behavior: The UAB pain behavior scale. Pain 1982;14:393–398.
  27. Norusis MJ: Statistical Packages for the Social Sciences, SPSS/PC+. New York, McGraw-Hill, 1988.
  28. Glennas A, Kvien TK, Andrup O, Karstensen B, Munthe E: Recent onset arthritis in the elderly: A 5 year longitudinal observational study. J Rheumatol 2000;27:101–108.
  29. Porter FL, Malhotra KM, Wolf CM, Morris JC, Miller JP, Smith MC: Dementia and response to pain in the elderly. Pain 1996;68:413–421.

    External Resources

  30. Benedetti F, Vighetti S, Ricco C, Lagna E, Bergamasco B, Pinessi L, Rainero I: Pain threshold and tolerance in Alzheimer’s disease. Pain 1999;80:377–382.

    External Resources

  31. Bertomeu A, Ros E, Zambón D, Vela M, Pérez-Ayuso RM, Targarona E, Trías M, Sanllehy C, Casals R, Ribo JM: Apolipoprotein E polymorphism and gallstones. Gastroenterology 1996;111:1603–1610.
  32. Lehtovirta M, Laakso MP, Soininen H, Helisalmi S, Mannermaa A, Helkala EL, Partanen K, Ryynänen M, Vainio P, Hartikainen P, Riekkinen PJ: Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neurosciences 1995;67:65–72.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50